Crinetics Pharmaceuticals Insider Sold Shares Worth $1,433,675, According to a Recent SEC Filing-March 2024-www.financetom.com

Crinetics Pharmaceuticals Insider Sold Shares Worth $1,433,675, According to a Recent SEC Filing

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Crinetics Pharmaceuticals Insider Sold Shares Worth $1,433,675, According to a Recent SEC Filing

Mar 26, 2024 1:54 PM

04:37 PM EDT, 03/26/2024 (MT Newswires) -- Jeff E. Knight, Chief Operating Officer, on March 22, 2024, sold 32,359 shares in Crinetics Pharmaceuticals ( CRNX ) for $1,433,675. Following the Form 4 filing with the SEC, Knight has control over a total of 52,580 shares of the company, with 52,580 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1658247/000120919124005081/xslF345X03/doc4.xml

Previous page： Neurocrine Biosciences Doses First Patient in Phase 2 Depressive Disorder Study Next page： DBRS Rates Mattr's New Debt Issuance

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Neurocrine Biosciences Doses First Patient in Phase 2 Depressive Disorder Study

Apr 3, 2024

11:46 AM EDT, 04/03/2024 (MT Newswires) -- Neurocrine Biosciences ( NBIX ) said Wednesday that it has dosed the first patient for its phase 2 clinical study of a potential treatment for major depressive disorder in adults. The study will assess the efficacy and safety of investigational compound NBI-1070770 in people who have major depressive disorder compared with placebo on...

DBRS Rates Mattr's New Debt Issuance

Apr 3, 2024

11:42 AM EDT, 04/03/2024 (MT Newswires) -- DBRS on Wednesday assigned a credit rating of B (high) with a recovery rating of RR6 and a positive trend to Mattr Corp.'s ( MTTRF ) C$175 million 7.250% senior unsecured notes due 2031, which closed on April 2. The credit rating assigned to this newly issued debt instrument is based on the...

Exclusive-Frontier's flight attendants oppose operations overhaul, demand negotiations

Apr 3, 2024

CHICAGO (Reuters) - Flight attendants at Frontier Airlines are opposing an overhaul to the airline's operations - a key element of its turnaround strategy - saying the changes are not covered by their labor agreement and will drastically upend their lives. In a letter to Frontier CEO Barry Biffle seen by Reuters, the Association of Flight Attendants (AFA) union said...

Why Ocugen Shares Are Popping Off

Apr 3, 2024

Ocugen Inc ( OCGN ) shares are trading higher by 14% to $1.58 during Wednesday’s session. The company yesterday provided an update on its business activities and financial status for the year ending 2023. Ocugen ( OCGN ) highlighted progress in its modifier gene therapy programs for blindness diseases. Key developments include promising results in the OCU400 Phase 1/2 study...